Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53

Genes and Development

Volumn 12, Issue 14, 1998, Pages 2102-2107

  Resnick Silverman, Lois ^a   St Clair, Selvon ^a   Maurer, Matthew ^a   Zhao, Kathy ^a   Manfredi, James J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Binding sites; DNA binding; P53 protein; Sequence specificity; Transcriptional activation; Tumor suppressor

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; DNA; MONOCLONAL ANTIBODY; NUCLEOTIDE; PROTEIN P53;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE ACTIVATION; GENE TARGETING; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; TUMOR SUPPRESSOR GENE;

EID: 0032528245     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.14.2102     Document Type: Article

References (31)

1. Aloni-Grinstein, R., I. Zan-Bar, I. Alboum, N. Goldfinger, and V. Rotter. 1993. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene 8: 3297-3305.
2. Balagurumoorthy, P., H. Sakamoto, M.S. Lewis, N. Zambrano G.M. Clore, A.M. Gronenborn, E. Appella, and R.E. Harrington. 1995. Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA. Proc. Natl. Acad. Sci. 92: 8591-8595.
3. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G.J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
4. Buckbinder, L., R. Talbott, S. Velasco-Miguel, I. Takenaka, B. Faha, B.R. Seizinger, and N. Kley. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649.
5. Cross, S.M., C.A. Sanchez, C.A. Morgan, M.K. Schimke, S. Ramel, R.L. Izerda, W.H. Rashkind, and B.J. Reid. 1995. A P53-dependent mouse spindle checkpoint. Science 267: 1353-1355.
6. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
7. El-Deiry, W.S., S.E. Kern, J.A. Pietenpol, K.W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nature Genet. 1: 45-49.
8. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.E. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
9. WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55: 2910-2919.
10. Friedlander, P., Y. Haupt, C. Prives, and M. Oren. 1996. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell. Biol. 16: 4961-4971.
11. Friedman, P.N., X. Chen, I. Bargonetti, and C. Prives. 1993. The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc. Natl. Acad. Sci. 90: 3319-3323.
12. Funk, W.D., D.T. Pak, R.H. Karas, W.E. Wright, and J.W. Shay. 1992. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol. 12: 2866-2871.
13. Gottlieb, T.M. and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287: 77-102.
14. Gu, W. and R.G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606.
15. Halazonetis, T.D., L.J. Davis, and A.N. Kandil. 1993. Wild-type p53 adopts a "mutant"-like conformation when bound to DNA. EMBO J. 12: 1021-1028.
16. Hupp, T.R., D.W. Meek, C.A. Midgely, and D.P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71: 875-886.
17. Hupp, T.R., A. Sparks, and D.P. Lane. 1995. Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83: 237-245.
18. Ko, L.J. and C. Prives. 1996. p53: Puzzle and paradigm. Genes & Dev. 10: 1054-1072.
19. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
20. Ludwig, R.L., S. Bates, and K.H. Vousden. 1996. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell. Biol. 16: 4952-4960.
21. Macleod, K.F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes & Dev. 9: 935-944.
22. Meek, D.W., S. Simon, U. Kikkawa, and W. Eckhart. 1990. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. EMBO J. 9: 3253-3260.
23. Miyashita, T. and J.C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
24. Mundt, M., T. Hupp, M. Fritsche, C. Merkle, S. Hansen, D. Lane, and B. Groner. 1997. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential. Oncogene 15: 237-244.
25. Nagaich, A.K., E. Appella, and R.E. Harrington. 1997a. DNA bending is essential for the site-specific recognition of DNA response elements by the DNA binding domain of the tumor suppressor protein p53. J. Biol. Chem. 272: 14842-14849.
26. Nagaich, A.K., V.B. Zhurkin, H. Sakamoto, A.A. Gorin, G.M. Clore, A.M. Gronenborn, E. Appella, and R.E. Harrington. 1997b. Architectural accommodation in the complex of four p53 DNA binding domain peptides with the p21/wafl/cip1 DNA response element. J. Biol. Chem. 272: 14830-14841.
27. Shaulsky, G., N. Goldfinger, A. Peled, and V. Rotter. 1991. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc. Natl. Acad. Sci. 88: 8982-8986.
28. Soddu, S., G. Blandino, G. Citro, R. Scardigli, G. Piaggio, A. Ferber, B. Calabretta, and A. Sacchi. 1994. Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood 83: 2230-2237.
29. Sugrue, M.M., D.Y. Shin, S.W. Lee, and S.A. Aaronson. 1997. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. 94: 9648-9653.
30. Takenaka, I., F. Morin, B.R. Seizinger, and N. Kley. 1995. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270: 5405-5411.
31. Wang, Y. and C. Prives. 1995. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases. Nature 376: 88-91.